ACN
45
-4
JPM
59
-3
PNC
53
-2
GLW
42
-3
BK
66
-2
KEY
31
2
TROW
50
2
AAP
29
-3
HCA
44
4
ORCL
52
-7
FOXA
60
-3
ADM
30
-3
VZ
39
2
PFG
27
-3
BWA
49
-6
HST
58
-4
JWN
61
5
PEP
42
-3
CMS
57
3
JNJ
36
3
ACN
45
-4
JPM
59
-3
PNC
53
-2
GLW
42
-3
BK
66
-2
KEY
31
2
TROW
50
2
AAP
29
-3
HCA
44
4
ORCL
52
-7
FOXA
60
-3
ADM
30
-3
VZ
39
2
PFG
27
-3
BWA
49
-6
HST
58
-4
JWN
61
5
PEP
42
-3
CMS
57
3
JNJ
36
3
Financhill
Back

BlueScope Steel 10K Form

Sell
44

BLSFY
BlueScope Steel

Last Price:
64.53
Seasonality Move:
8.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BLSFY News And Ratings

See the #1 stock for the next 7 days that we like better than BLSFY

BLSFY Financial Statistics

Sales & Book Value

Annual Sales: $11.15B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $81.60
Price / Book: 0.79

Profitability

EPS (TTM): 5.85160
Net Income (TTM): $527.63M
Gross Margin: $4.35B
Return on Equity: 7.07%
Return on Assets: 5.04%

BlueScope Steel Earnings Forecast

Key BlueScope Steel Financial Ratios

  • The Gross Profit Margin over the past 24 years for BLSFY is 38.99%.
  • The Selling, General & Administrative Expenses for BLSFY have been equal to 19.22% of Gross Profit Margin.
  • The Research & Development expenses have been 0.20% of Revenue.
  • The Interest Expense is 4.11% of Operating Income.
  • The Net Earning history of BLSFY is 4.74% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 14 years.

BlueScope Steel Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Metals & Mining
Sector: Materials
Current Symbol: BLSFY
Website: bluescope.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 1.97
Quick Ratio: 0.87

Price-to-Earnings

Trailing P/E Ratio: 11.02
Forward P/E Ratio: 0

BLSFY Technical Analysis vs Fundamental Analysis

Sell
44
BlueScope Steel (BLSFY) is a Sell

Is BlueScope Steel a Buy or a Sell?

  • BlueScope Steel stock is rated a Sell
    The current BlueScope Steel [BLSFY] share price is $64.53. The Score for BLSFY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.